Neurotechnology
Pioneers and Entrepreneurs to Highlight October Investment Conference
Some of the world's leading researchers and entrepreneurs in neural
prostheses, neurostimulation, and advanced brain sensing will participate
in the second annual Neurotech Leaders Forum, to be held in San
Francisco October 3, 2002. The full-day event offers an opportunity
for researchers and executives in the neurotechnology field to interact
with venture capital firms and other funding organizations.
Included in the event's agenda are presentations from leading-edge
firms developing devices to restore hearing to deaf people, vision
to blind people, and muscular control to people suffering from stroke,
spinal cord injury, and other neurological diseases and disorders.
Executives from several start-ups and venture capital firms active
in the neuro space will be speaking at the event. Peter Baillie,
CEO of Epic Biosonics Inc. in Victoria, B.C., will describe his
firm's efforts developing the first fully implantable cochlear prosthesis.
Another panelist is Robert Greenberg, M.D., Ph.D., CEO of Second
Sight LLC in Valencia, CA, which is developing a retinal implant
to treat blindness.
On the venture capital panel, Roger Quy, Ph.D., a partner with Technology
Partners of Palo Alto, CA, Heath Lukatch, Ph.D., a partner with
US Bancorp. Piper Jaffrey in Menlo Park, CA, Andrew Firlik, a principal
of Canaan Partners in Rowayton, CT, and Daniel O’Connell with
Neuro Ventures Capital in Charlottsville, VA will participate.
Keynote speaker at this year’s event will be Dr. Warren Grill,
one of the nation’s leading experts in neural stimulation,
neural prostheses, and neural control. Dr. Grill is the Elmer L.
Lindseth Assistant Professor of Biomedical Engineering at Case Western
Reserve University and a principal investigator at the Cleveland
FES Center. Quallion LLC, a manufacturer of batteries for implanted
stimulators, is the platinum sponsor of this year's Forum.
Other speakers at the Forum include Ann Bunnenberg, Ph.D, president
of Electrical Geodesics, Inc. in Portland, OR, and Arthur Prochazka,
Ph.D., founder of Neurokinetics, Inc., in Edmonton, AB. Session
topics include partnering opportunities with bio/pharma firms, distribution
and marketing issues, the reimbursement outlook for stimulation
devices, and developing supportive clinician communities. James
Cavuoto, editor and publisher of Neurotech Business Report, will
serve as moderator for the roundtable discussions.
This year’s event will take place at the Hyatt Regency San
Francisco Airport. Subscribers to Neurotech Business Report save
$100 off the registration fee of $695. For information on attending
or sponsorship opportunities, contact Neurotech Reports at 415 546
1259 or visit our web site at: www.neurotechreports.com/pages/leadersforum02.html
##